At mAbxience we integrate cutting-edge technologies like single-use bioreactors and ensure flexibility and scalability in every project, delivering high-quality biopharmaceutical products efficiently and safely to the market. But how?

In a previous blog, we explored the transformative advancements in custom biopharmaceutical development and manufacturing, highlighting how innovative technologies are enabling tailored solutions with unprecedented precision and efficiency. Building on this foundation, mAbxience continues to drive excellence in the biotech industry through three main aspects that define our services: our expertise in the successful development and launch of biopharmaceuticals, our efficient manufacturing platform and our adaptable CDMO capabilities brought by our state-of-the-art global facilities.

Expertise in action: biosimilars and beyond

mAbxience leverages its extensive experience in biosimilars development, manufacturing and global market supply to offer comprehensive CDMO services, ensuring fast, efficient and reliable market entry for its partners. Our in-house R&D platform provides seamless control over quality and delivery across the entire development lifecycle, from cell line development to drug substance (DS). Our IP and regulatory teams ensure compliance and smooth approvals, leveraging strong relationships with regulatory authorities worldwide.

Streamlining biopharmaceutical production with single-use bioreactors

A standout feature of our approach is the use of single-use bioreactors, offering remarkable flexibility and scalability to tailor production processes to each project’s needs. These bioreactors enable seamless transitions from small-scale development to large-scale production, quickly adapting to changing requirements while minimizing contamination risks and reducing the need for extensive cleaning and validation, ensuring safe production and accelerated, efficient turnaround.

Double-source production and global regulatory experience

mAbxience’s global presence and strategic alliances ensure the accessibility of our high-quality medicines worldwide, with operations in over 100 markets and partnerships with 30+ global and regional partners. Our state-of-the-art plants in Europe and South America, equipped with identical technologies and manufacturing setups, provide optimized transfer and adaptability, supporting our commitment to delivering affordable healthcare solutions.

At mAbxience, we go beyond for our partners and make things happen. Continuous improvement, advanced technologies like single-use bioreactors, our 14+ years of experience in biologics development and production ensure we deliver products fast and efficiently. By fostering strategic partnerships and maintaining robust global operations, we help our partners bring their biopharmaceutical products to market confidently.

Contact us at contact@mabxience.com to discover how we can support your biotech projects with our cutting-edge technologies and comprehensive CDMO services.